"Prognostic Value of CD200 in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality"
Not yet recruitingOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
February 15, 2024
Primary Completion Date
February 6, 2025
Study Completion Date
February 6, 2025
Conditions
Hematological Malignancies
Interventions
DIAGNOSTIC_TEST
Flowcytometry on bone marrow aspiration
Flowcytometry on bone marrow aspiration
All Listed Sponsors
lead
Sohag University
OTHER
NCT06258629 - "Prognostic Value of CD200 in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality" | Biotech Hunter | Biotech Hunter